Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation

This is a clinical practice guideline for patients with chronic lymphocytic leukemia (CLL). The guideline examines the role of allogeneic hematopoietic cell transplantation (allo-HCT) for patients with CLL in an era of highly active targeted therapies. The recommendations emerge from comparing allo-HCT against novel therapies for treatment of CLL, at various disease stages.